During the past few decades, fungal infections are the commonly prevalent diseases from which a large proportion of the human population suffers 1-5. The increased emergence of both the superficial and systemic fungal infections has led to the massive increase in the rate of mortality, especially in the immuno-compromised individuals, those suffering from tuberculosis, cancer or AIDS 6,7. In clinic, azoles, especially triazole antifungal agents, were used most widely and efficiently. For example, fluconazole, voriconazole and itraconazole, presently play an important role in the treatment of fungal infections. However, their clinical use has been limited by the emergence of drug resistance, high risk of toxicity, insufficiencies in their antifungal activity and undesirable side effects 8-10. Hence, there is still a need to develop the safe and efficient chemotherapeutic agents with potent broad spectrum antifungal activities 10. EXPERIMENTAL Analytical TLC was carried out on Silica Gel 60 F254 plates (E. Merck) with detection by fluorescence and/or by charring with 10 % (v/v) H2SO4 in EtOH. Column chromatograph was performed on silica gel (200-300 mesh, Qindao Ocean Chemical Co., China). All chemicals and solvents were purchased from commercial sources unless specified otherwise. 1 H and 13 C NMR spectra were recorded in CDCl3, using